Three decades of the Polish Gastric Cancer Study; a special reference to preliminary results from the clinical trial on extended lymphadenectomy;Trzy dekady Polskich Badań nad Rakiem Żoła̧dka ze szczególnym uwzglȩdnieniem wstȩpnych wyników prospektywnego badania klinicznego nad poszerzonym wyciȩciem wȩzłow chŁonnych

Polski Przeglad Chirurgiczny

Volumn 78, Issue 4, 2006, Pages 345-365

  Popiela, Tadeusz ^a,b   Kulig, Jan ^a   Kołodziejczyk, Piotr ^a   Berner, Jan ^a   Bandurski, Roman ^a   Czupryna, Antoni ^a   Drews, Michał ^a   Fra̧czek, Mariusz ^a   Gruca, Zbigniew ^a   Jeziorski, Arkadiusz ^a   Krawczyk, Marek ^a   Marlicz, Krzysztof ^a   Misiuna, Paweł ^a   Piotrowski, Zdzisław ^a   Puchalski, Zbigniew ^a   Sierzȩga, Marek ^a   Stachura, Jerzy ^a   Szczepanik, Antoni M ^a   Tenderenda, Michał ^a   Wajda, Zbigniew ^a   Wallner, Grzegorz ^a   Zembala, Marek ^a   more..

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b Jagiellonian University ^*  (Poland)

Author keywords

Gastrectomy; Gastric cancer; Lymphadenectomy

Indexed keywords

ARTICLE; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; HUMAN; LYMPH NODE; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MORBIDITY; POSTOPERATIVE COMPLICATION; STOMACH CANCER;

EID: 33646344212     PISSN: 0032373X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Hohenberger P, Gretschel S: Gastric cancer. Lancet 2003; 362: 305-15.
2. Akoh JA, Macintyre IMC: Improving survival in gastric-cancer - review of 5-year survival rates in english-language publications from 1970. Br J Surg 1992; 79: 293-99.
3. Nakamura K, Ueyama T, Yao T et al.: Pathology and prognosis of gastric-carcinoma - findings in 10,000 patients who underwent primary gastrectomy. Cancer 1992; 70: 1030-37.
4. Kim JP, Lee JH, Kim SJ et al.: Clinicopathologic characteristics and prognostic factors in 10783 patients with gastric cancer. Gastric Cancer 1998; 1: 125-33.
5. Allum WH, Griffin SM, Watson A et al.: Guidelines for the management of oesophageal and gastric cancer. Gut 2002; 50: 1-23.
6. McCulloch P, Niita ME, Kazi H et al.: Gastrectomy with extended lymphadenectomy for primary treatment of gastric cancer. Br J Surg 2005; 92: 5-13.
7. Hartgrink HH, van de Velde CJ, Putter H et al.: Extended lymph node dissection for gastric cancer: Who may benefit? Final results of the randomized Dutch Gastric Cancer Group Trial. J Clin Oncol 2004; 22: 2069-77.
8. Noguchi Y, Imada T, Matsumoto A et al.: Radical surgery for gastric-cancer - a review of the Japanese experience. Cancer 1989; 64: 2053-62.
9. Popiela T, Kulig J, Kolodziejczyk P: The Polish Gastric Cancer Study Group. 20 Jahre Erfahrung mit der multimodalen Behandlung von Patienten mit Magenkarzinom in Polen. Zentralbl Chir 2001; 126: 763-71.
10. Popiela T, Kulig J, Kołodziejczyk P et al.: Changing patterns of gastric carcinoma over the past two decades in a single institution: clinicopathological findings in 1557 patients. Scand J Gastroenterol 2002; 37: 561-67.
11. Popiela T, Kulig J, Kołodziejczyk P et al.: Long-term results of surgery for early gastric cancer. Br J Surg 2002; 89: 1035-42.
12. Takeda J, Koufuji K, Kodama IT et al.: Paraaortic lymph node dissection for the treatment of advanced gastric cancer. Kurume Med J 1993; 40: 101-06.
13. Yonemura Y, Katayama K, Kamata T et al.: Surgical-treatment of advanced gastric-cancer with metastasis in paraaortic lymph-node. Int Surg 1991; 76: 222-25.
14. Nakane Y, Okamura S, Masuya Y et al.: Incidence and prognosis of para-aortic lymph node metastasis in gastric cancer. Hepatogastroenterology 1998; 45: 1901-06.
15. Bonenkamp JJ, Songun I, Hermans J et al.: Randomized Comparison of morbidity after d1 and d2 dissection for gastric-cancer in 996 Dutch Patients. Lancet 1995; 345: 745-48.
16. Cuschieri A, Fayers P, Fielding J et al.: Postoperative morbidity and mortality after D-1 and D-2 resections for gastric cancer: Preliminary results of the MRC randomized controlled surgical trial. Lancet 1996; 347: 995-99.
17. Roukos DH, Lorenz M, Encke A: Evidence of survival benefit of extended (D2) lymphadenectomy in Western patients with gastric cancer based on a new concept: A prospective long-term follow-up study. Surgery 1998; 123: 573-78.
18. Japanese Gastric Cancer Association. Japanese Classification of Gastric Carcinoma - 2nd English Edition. Gastric Cancer 1998; 1: 10-24.
19. Sobin L, Wittekind C: TNM Classification of Malignant Tumors: International Union Against Cancer. New York, Wiley 1997.
20. Kodera Y, Schwarz RE, Nakao A: Extended lymph node dissection in gastric carcinoma: Where do we stand after the Dutch and British randomized trials? J Am Coll Surg 2002; 195: 855-64.
21. Cuschieri A, Weeden S, Fielding J et al.: Patient survival after D-1 and D-2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Br J Cancer 1999; 79: 1522-30.
22. Bonenkamp JJ, Hermans J, Sasako M et al.: Extended lymph-node dissection for gastric cancer. N Engl J Med 1999; 340: 908-14.
23. Degiuli M, Sasako M, Ponzetto A et al.: Extended lymph node dissection for gastric cancer: results of a prospective, multi-centre analysis of morbidity and mortality in 118 consecutive cases. Eur J Surg Oncol 1997; 23: 310-14.
24. Degiuli M, Sasako M, Calgaro M et al.: Morbidity and mortality after D1 and D2 gastrectomy for cancer: Interim analysis of the Italian Gastric Cancer Study Group (IGCSG) randomized surgical trial. Eur J Surg Oncol 2004; 30: 303-08.
25. Wu CW, Hsiung CA, Lo SS et al.: Randomized clinical trial of morbidity after D1 and D3 surgery for gastric cancer. Br J Surg 2004; 91: 283-87.
26. Sano T, Sasako M, Yamamoto S et al.: Gastric cancer surgery: Morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy - Japan Clinical Oncology Group Study 9501. J Clin Oncol 2004; 22: 2767-73.
27. Hartgrink HH, van de Velde CJ: Status of extended lymph node dissection: locoregional control is the only way to survive gastric cancer. J Surg Oncol 2005; 90: 153-65.
28. Maruyama K, Sasako M, Kinoshita T et al.: Pancreas-preserving total gastrectomy for proximal gastric-cancer. World J Surg 1995; 19: 532-36.
29. Kitamura K, Nishida S, Yamamoto K et al.: Lymph node metastasis in gastric cancer in the upper third of the stomach - surgical treatment on the basis of the anatomical distribution of positive node. Hepatogastroenterology 1998; 45: 281-85.
30. Kwon SJ, Lee JI, Choi DW et al.: Prognostic impact of splenectomy on gastric cancer: Results of the Korean Gastric Cancer Study Group. World J Surg 1997; 21: 837-44.
31. Wanebo HJ, Kennedy BJ, Winchester DP et al.: Role of splenectomy in gastric cancer surgery: Adverse effect of elective splenectomy on longterm survival. J Am Coll Surg 1997; 185: 177-84.
32. Onate-Ocana LF, Cortes-Cardenas SA, Aiello-Crocifoglio V et al.: Preoperative multivariate prediction of morbidity after gastrectomy for adenocarcinoma. Ann Surg Oncol 2000; 7: 281-88.
33. Yasuda K, Shiraishi N, Adachi Yet al.: Risk factors for complications following resection of large gastric cancer. B J Surg 2001; 88: 873-77.